mRNA |
Crizotinib |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.04 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.04 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.074 |
0.04 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.04 |
mRNA |
UNC1215 |
GDSC1000 |
pan-cancer |
AAC |
0.071 |
0.04 |
mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.04 |
mRNA |
BRD-K30748066 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
0.04 |
mRNA |
fluvastatin |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.04 |
mRNA |
Panobinostat |
CCLE |
pan-cancer |
AAC |
0.083 |
0.04 |
mRNA |
HG-5-113-01 |
GDSC1000 |
pan-cancer |
AAC |
0.094 |
0.04 |